查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1794771

全球整形外科植入金黃色葡萄球菌感染疾病診斷與治療市場

Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 278 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球整形外科植入金黃色葡萄球菌感染疾病診斷和治療市場規模將達到 30 億美元

全球整形外科植入金黃色葡萄球菌感染疾病診斷和治療市場規模預計在2024年達到24億美元，預計2024年至2030年期間的複合年成長率為3.2%，到2030年將達到30億美元。診斷是本報告分析的細分市場之一，預計其複合年成長率為2.4%，到分析期結束時將達到17億美元。治療細分市場在分析期間內的複合年成長率預計為4.5%。

美國市場規模估計為 6.661 億美元，中國市場預計複合年成長率為 5.9%

預計到2024年，美國整形外科植入金黃色葡萄球菌感染疾病診斷和治療市場規模將達到6.661億美元。作為世界第二大經濟體，中國市場規模預計到2030年將達到5.795億美元，在2024-2030年的分析期間內，複合年成長率為5.9%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為1.3%和2.4%。在歐洲，預計德國市場的複合年成長率為1.8%。

全球整形外科植入診斷和治療市場中的金黃色葡萄球菌感染疾病—主要趨勢和促進因素摘要

是什麼推動了整形外科植入中金黃色葡萄球菌檢測的進步？

金黃色葡萄球菌（S. aureus），尤其是其抗甲氧西林菌株（MRSA），是整形外科植入中假體周圍關節感染（PJIs）的主要原因。這些感染疾病可導致嚴重的併發症，包括植入斷裂、骨髓炎和敗血症。快速準確的檢測和有針對性的治療對於臨床結果至關重要。傳統的診斷依賴微生物培養，這既耗時又經常產生假陰性結果。如今，PCR、次世代定序（NGS）和免疫測量等分子診斷方法能夠早期可靠地檢測金黃色葡萄球菌和相關的生物膜形成病原體。

FDG-PET 和 WBC 標記 SPECT/CT 等先進影像技術也被用於感染定位。能夠檢測抗藥性基因（例如 mecA）的即時生物感測器和多重檢測板也正在進入臨床應用。這些工具正在幫助骨科醫生和感染疾病專家更快地做出更明智的清創手術和抗生素選擇。

新的治療方法和塗層會改變植入植入的照護嗎？

抗菌塗層的創新，例如銀奈米顆粒、抗生素水門汀和碘活化表面，正被應用於診斷以外的領域，以防止植入上形成生物膜。基於病原體基因圖譜的個人化抗生素治療方案正在提高根除率。長效抗生素載體（微珠、間隔物）可實現局部藥物輸送，且不產生全身毒性。

人們正在探索將診斷和治療結合到單一植入或塗層中用於術中應用，而免疫療法和基於噬菌體的抗菌療法正在臨床開發中，以更特異性針對抗生素抗藥性菌株。

為什麼整形外科專家強調早期治療？

隨著全球膝關節、髖關節和脊椎移植使用量的不斷增加，感染預防和控制已成為重中之重。金黃色葡萄球菌感染疾病顯著增加再次手術率、住院時間和醫療費用。外科醫生正在尋求能夠在手術過程中即時識別病原體的工具，以避免不必要的拔牙。醫院正在採用全面的感染控制通訊協定，包括術前篩檢、術中診斷和術後監測。

是什麼推動了整形外科黃色葡萄球菌感染疾病市場的成長？

這一市場成長受到多種因素的推動，這些因素與整形外科手術量、診斷技術的創新以及抗藥性趨勢有關。全球全關節重建的興起，增加了植入相關感染的風險和發生率。快速分子診斷和生物膜成像工具的技術進步正在提高臨床檢出率。新型抗菌材料和局部給藥系統正在拓展治療方案。最後，抗生素抗藥性的上升刺激了對新型療法的投資，從而催生了對整形外科領域精準、主動的感染控制解決方案的需求。

部分

組件（診斷、治療）；最終用途（醫院最終用途、門診手術中心最終用途、其他最終用途）

受訪公司範例

  • Abbott Laboratories
  • Beckman Coulter Inc.
  • Becton Dickinson（BD）
  • BioMerieux SA
  • C2Dx, Inc.
  • Cepheid
  • Hologic（Molecular Diagnostics）
  • Johnson & Johnson MedTech
  • MediWound
  • Merck KGaA
  • Micreos（Staphefekt）
  • Ortho Clinical Diagnostics
  • Pfizer Inc.
  • Roche（Roche Diagnostics）
  • Sabiad
  • Schwitz Biotech
  • Siemens Healthineers
  • Stryker Corporation
  • Thermo Fisher Scientific Inc.
  • Wellona Pharma

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 沒有遵循典型的 LLM 或特定於行業的 SLM查詢，而是建立了一個從世界各地的專家收集的內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP38106

Global Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market to Reach US$3.0 Billion by 2030

The global market for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants estimated at US$2.4 Billion in the year 2024, is expected to reach US$3.0 Billion by 2030, growing at a CAGR of 3.2% over the analysis period 2024-2030. Diagnosis, one of the segments analyzed in the report, is expected to record a 2.4% CAGR and reach US$1.7 Billion by the end of the analysis period. Growth in the Treatment segment is estimated at 4.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$666.1 Million While China is Forecast to Grow at 5.9% CAGR

The Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants market in the U.S. is estimated at US$666.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$579.5 Million by the year 2030 trailing a CAGR of 5.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.3% and 2.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.8% CAGR.

Global Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market - Key Trends & Drivers Summarized

What’s Driving Advances in Staphylococcus Aureus Detection in Orthopedic Implants?

Staphylococcus aureus (S. aureus), particularly its methicillin-resistant strain (MRSA), is a major cause of periprosthetic joint infections (PJI) in orthopedic implants. These infections can lead to severe complications, including implant failure, osteomyelitis, and sepsis. Rapid, accurate detection and targeted treatment are critical for clinical outcomes. Conventional diagnosis relied on microbial culture, which is slow and often yields false negatives. Today, molecular diagnostics-like PCR, next-generation sequencing (NGS), and immunoassays-are enabling earlier and more reliable detection of S. aureus and associated biofilm-forming pathogens.

Advanced imaging modalities, such as FDG-PET and WBC-labeled SPECT/CT, are also being used to localize infections. Point-of-care biosensors and multiplexed panels capable of detecting resistance genes (e.g., mecA) are entering clinical use. These tools help orthopedic surgeons and infectious disease specialists make informed debridement and antibiotic choices more quickly.

Are Novel Therapies and Coatings Transforming Post-Implant Management?

Beyond diagnostics, innovations in antimicrobial coatings-silver nanoparticles, antibiotic-loaded cements, and iodine-activated surfaces-are being employed to prevent biofilm formation on implants. Personalized antibiotic regimens based on genetic profiling of pathogens are improving eradication rates. Long-acting antibiotic carriers (beads, spacers) provide localized drug delivery without systemic toxicity.

Theranostic approaches-where diagnosis and therapy are combined in a single implant or coating-are being explored for intraoperative applications. Immunotherapies and phage-based antibacterial therapies are under clinical development, targeting antibiotic-resistant strains with greater specificity.

Why Are Orthopedic Specialists Focusing on Early Intervention?

As the global volume of knee, hip, and spinal implants rises, infection prevention and control have become top priorities. S. aureus infections significantly increase revision rates, hospitalization duration, and costs. Surgeons are demanding tools that enable real-time pathogen identification during surgery to avoid unnecessary explantation. Hospitals are adopting comprehensive infection management protocols-including preoperative screening, intraoperative diagnostics, and post-op surveillance.

What’s Powering the Growth in the Orthopedic S. Aureus Infection Market?

The growth in this market is driven by several factors related to orthopedic surgery volumes, diagnostic innovation, and resistance trends. The rise in joint replacement procedures globally is increasing risk and incidence of implant-related infections. Technological advancements in rapid molecular diagnostics and biofilm imaging tools are improving clinical detection rates. New antimicrobial materials and localized drug-delivery systems are expanding treatment options. Finally, the spread of antibiotic resistance is fueling investment in novel therapies, creating demand for precise and aggressive infection control solutions in orthopedic settings.

SCOPE OF STUDY:

The report analyzes the Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Diagnosis, Treatment); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • Abbott Laboratories
  • Beckman Coulter Inc.
  • Becton Dickinson (BD)
  • BioMerieux SA
  • C2Dx, Inc.
  • Cepheid
  • Hologic (Molecular Diagnostics)
  • Johnson & Johnson MedTech
  • MediWound
  • Merck KGaA
  • Micreos (Staphefekt)
  • Ortho Clinical Diagnostics
  • Pfizer Inc.
  • Roche (Roche Diagnostics)
  • Sabiad
  • Schwitz Biotech
  • Siemens Healthineers
  • Stryker Corporation
  • Thermo Fisher Scientific Inc.
  • Wellona Pharma

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Post-Operative Infections Drives Demand for Advanced Diagnostic Solutions
    • Increase in Joint Replacement and Trauma Surgeries Spurs Need for S. aureus Monitoring
    • Growing Focus on Implant-Associated Infections Throws Spotlight on Early Detection Technologies
    • Development of Rapid Molecular Diagnostics Enhances Clinical Decision-Making
    • Antimicrobial Coating Innovations Strengthen Business Case for Preventative Orthopedic Implants
    • Regulatory Guidelines for Surgical Site Infections Drive Compliance-Based Adoption
    • AI and Machine Learning in Diagnostic Algorithms Accelerate Infection Identification Accuracy
    • Expansion of Outpatient Orthopedic Care Creates Demand for Point-of-Care Testing Kits
    • Rise in Antibiotic Resistance Fuels R&D in Novel Therapeutics and Diagnostic Pathways
    • Healthcare Cost Containment Strategies Encourage Early Diagnosis and Treatment
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • JAPAN
    • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CHINA
    • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: China 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: China 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • EUROPE
    • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • FRANCE
    • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: France 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: France 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • GERMANY
    • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • INDIA
    • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: India 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: India 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AFRICA
    • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

IV. COMPETITION